Drugs / HS-10501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06359600 | Mar 2024 → Jan 2025 | — | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HS-10501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06359600 ↗ |
| Route | Oral | “Administered orally” NCT06359600 ↗ |